We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $3.51B
1-Year Est. Return 13.98%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+13.98%
3 Year Est. Return
+39.43%
5 Year Est. Return
+43.32%
10 Year Est. Return
+133.07%
AUM
$341M
AUM Growth
-$852M
Cap. Flow
-$875M
Cap. Flow %
-256.9%
Top 10 Hldgs %
61.35%
Holding
204
New
1
Increased
1
Reduced
75
Closed
122

Top Buys

Rank Stock Value
1
AMU
ETRACS Alerian MLP Index ETN
AMU
+$562K
2
PRCP
Perceptron Inc
PRCP
+$91.4K

Sector Composition

Rank Sector Weight
1 Financials 6.67%
2 Communication Services 2.66%
3 Healthcare 1.09%
4 Technology 0.9%
5 Consumer Discretionary 0.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESRX
201
DELISTED
Express Scripts Holding Company
ESRX
-11,465
Closed -$726K
PX
202
DELISTED
Praxair Inc
PX
-3,853
Closed -$538K
MON
203
DELISTED
Monsanto Co
MON
-7,180
Closed -$860K
CELG
204
DELISTED
Celgene Corp
CELG
-9,014
Closed -$1.31M

Similar funds

Aspiriant LLC's Q4 2017 Portfolio in Review

As of Q4 2017, Aspiriant LLC held 204 positions worth $341M, down 71% from $1.19B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Aspiriant LLC withdrew a net $875M in Q4 2017, closing 122 positions and reducing 75 holdings. Its most notable exit was iShares US Real Estate ETF, an estimated $32.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 6.7% of assets, up from 4.8% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Aspiriant LLC opened a new position in Perceptron Inc worth $99K.

  • Aspiriant LLC's largest Q4 2017 buy was Perceptron Inc: 10,143 shares worth $99K.
  • Aspiriant LLC added most to ETRACS Alerian MLP Index ETN in Q4 2017, an estimated $562K increase.
  • Aspiriant LLC's biggest Q4 2017 reduction was iShares MSCI Global Min Vol Factor ETF, cutting an estimated $76.3M.
  • Aspiriant LLC fully exited iShares US Real Estate ETF in Q4 2017, selling an estimated $32.9M.
  • Aspiriant LLC's ten largest holdings make up 61% of its $341M portfolio in Q4 2017.
  • Aspiriant LLC opened 1 new position and closed 122 in Q4 2017.
  • Aspiriant LLC's portfolio value fell 71% quarter-over-quarter to $341M.

Based on Aspiriant LLC's 13F filing for Q4 2017, filed 31 Jan 2018.